Zhenghui Gordon Jiang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 13 | 2024 | 1960 | 1.750 |
Why?
|
Apolipoproteins B | 9 | 2021 | 385 | 1.450 |
Why?
|
Hepatitis, Alcoholic | 2 | 2021 | 110 | 1.350 |
Why?
|
Lipoproteins, VLDL | 6 | 2018 | 201 | 1.250 |
Why?
|
Elasticity Imaging Techniques | 4 | 2021 | 398 | 1.220 |
Why?
|
Adenosine Deaminase | 3 | 2021 | 253 | 1.180 |
Why?
|
Lipoproteins | 3 | 2021 | 879 | 1.130 |
Why?
|
Pyrophosphatases | 2 | 2021 | 142 | 0.980 |
Why?
|
Apyrase | 6 | 2019 | 376 | 0.890 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1656 | 0.810 |
Why?
|
Fatty Liver | 5 | 2024 | 809 | 0.790 |
Why?
|
Liver Diseases, Alcoholic | 3 | 2024 | 162 | 0.760 |
Why?
|
Lipoproteins, HDL | 3 | 2021 | 682 | 0.760 |
Why?
|
Kupffer Cells | 1 | 2021 | 143 | 0.740 |
Why?
|
Autocrine Communication | 1 | 2021 | 168 | 0.720 |
Why?
|
Paracrine Communication | 1 | 2021 | 278 | 0.680 |
Why?
|
Basal Metabolism | 1 | 2021 | 163 | 0.680 |
Why?
|
End Stage Liver Disease | 2 | 2021 | 370 | 0.670 |
Why?
|
Liver | 8 | 2024 | 7574 | 0.590 |
Why?
|
Nutrition Surveys | 8 | 2024 | 1738 | 0.580 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2017 | 31 | 0.560 |
Why?
|
Hepatorenal Syndrome | 1 | 2018 | 76 | 0.560 |
Why?
|
Aspartate Aminotransferases | 3 | 2019 | 414 | 0.540 |
Why?
|
Serum | 1 | 2017 | 206 | 0.530 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 842 | 0.530 |
Why?
|
Mastocytosis, Systemic | 1 | 2018 | 102 | 0.530 |
Why?
|
Lipase | 1 | 2018 | 321 | 0.510 |
Why?
|
Liver Failure | 1 | 2018 | 252 | 0.510 |
Why?
|
Alanine Transaminase | 3 | 2019 | 606 | 0.500 |
Why?
|
Antigens, CD | 6 | 2024 | 4035 | 0.470 |
Why?
|
Triglycerides | 5 | 2015 | 2463 | 0.460 |
Why?
|
Enteric Nervous System | 1 | 2017 | 213 | 0.460 |
Why?
|
Aspirin | 2 | 2016 | 3135 | 0.460 |
Why?
|
Gene Deletion | 1 | 2021 | 2673 | 0.430 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 160 | 0.410 |
Why?
|
Colonoscopy | 2 | 2019 | 1409 | 0.410 |
Why?
|
Monocytes | 1 | 2021 | 2605 | 0.390 |
Why?
|
Models, Molecular | 8 | 2014 | 5402 | 0.370 |
Why?
|
Alcoholism | 1 | 2021 | 1980 | 0.360 |
Why?
|
Lipids | 1 | 2021 | 3342 | 0.350 |
Why?
|
Liver Diseases | 1 | 2019 | 1305 | 0.350 |
Why?
|
Colon | 1 | 2017 | 1800 | 0.320 |
Why?
|
Egg Proteins, Dietary | 2 | 2006 | 6 | 0.320 |
Why?
|
Colitis | 1 | 2017 | 1242 | 0.310 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.290 |
Why?
|
Hepatic Encephalopathy | 3 | 2018 | 144 | 0.280 |
Why?
|
Protein Structure, Tertiary | 11 | 2014 | 3771 | 0.280 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1820 | 0.280 |
Why?
|
Keratin-18 | 2 | 2016 | 37 | 0.260 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2271 | 0.260 |
Why?
|
Cholangitis, Sclerosing | 2 | 2019 | 179 | 0.250 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2496 | 0.240 |
Why?
|
Macrophages | 4 | 2019 | 5799 | 0.240 |
Why?
|
Microfilament Proteins | 3 | 2009 | 1133 | 0.240 |
Why?
|
Crohn Disease | 1 | 2017 | 2295 | 0.240 |
Why?
|
Blood Proteins | 2 | 2009 | 1191 | 0.230 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2403 | 0.230 |
Why?
|
Trypsin | 1 | 2005 | 491 | 0.230 |
Why?
|
Cholesterol | 3 | 2021 | 2914 | 0.220 |
Why?
|
Egg Proteins | 3 | 2010 | 58 | 0.220 |
Why?
|
Lipoproteins, LDL | 3 | 2018 | 644 | 0.210 |
Why?
|
Apolipoprotein C-III | 2 | 2017 | 210 | 0.210 |
Why?
|
Obesity | 2 | 2021 | 13091 | 0.190 |
Why?
|
Insulin Resistance | 1 | 2015 | 3986 | 0.190 |
Why?
|
Portal Vein | 1 | 2024 | 435 | 0.190 |
Why?
|
Membrane Proteins | 1 | 2018 | 7876 | 0.180 |
Why?
|
Mitochondria, Liver | 1 | 2021 | 190 | 0.180 |
Why?
|
Humans | 50 | 2024 | 767991 | 0.180 |
Why?
|
Phosphoproteins | 2 | 2009 | 2450 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2021 | 254 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2748 | 0.180 |
Why?
|
Male | 29 | 2024 | 364641 | 0.180 |
Why?
|
Acetyltransferases | 1 | 2021 | 231 | 0.180 |
Why?
|
Protein Folding | 4 | 2009 | 871 | 0.180 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1032 | 0.180 |
Why?
|
Middle Aged | 22 | 2024 | 223422 | 0.180 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3780 | 0.170 |
Why?
|
Cross-Sectional Studies | 7 | 2018 | 26375 | 0.160 |
Why?
|
Protein Structure, Secondary | 5 | 2014 | 1216 | 0.160 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15944 | 0.160 |
Why?
|
Adult | 17 | 2024 | 223583 | 0.160 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2019 | 128 | 0.150 |
Why?
|
Inflammation | 3 | 2023 | 10871 | 0.150 |
Why?
|
Female | 25 | 2024 | 397113 | 0.150 |
Why?
|
Adipose Tissue, White | 1 | 2021 | 371 | 0.150 |
Why?
|
Ascites | 2 | 2018 | 338 | 0.140 |
Why?
|
Coffee | 1 | 2021 | 594 | 0.140 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 489 | 0.140 |
Why?
|
Pancreatitis | 1 | 2023 | 1087 | 0.130 |
Why?
|
Chromatography, Gel | 2 | 2014 | 636 | 0.130 |
Why?
|
Dextran Sulfate | 1 | 2017 | 258 | 0.130 |
Why?
|
Mutation, Missense | 3 | 2011 | 2592 | 0.130 |
Why?
|
Liver Regeneration | 1 | 2017 | 214 | 0.130 |
Why?
|
Defecation | 1 | 2017 | 191 | 0.130 |
Why?
|
Hepatitis, Chronic | 1 | 2016 | 53 | 0.130 |
Why?
|
Animals, Genetically Modified | 1 | 2021 | 1564 | 0.130 |
Why?
|
Circular Dichroism | 2 | 2007 | 337 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22381 | 0.130 |
Why?
|
Factor VII | 1 | 2015 | 139 | 0.120 |
Why?
|
Teaching Rounds | 1 | 2019 | 282 | 0.120 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 776 | 0.120 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 96 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1323 | 0.120 |
Why?
|
Hyperammonemia | 1 | 2015 | 80 | 0.110 |
Why?
|
United States | 8 | 2024 | 73027 | 0.110 |
Why?
|
Ammonia | 1 | 2015 | 247 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 806 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2015 | 526 | 0.110 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 173 | 0.110 |
Why?
|
Purines | 1 | 2017 | 615 | 0.110 |
Why?
|
Insulin-Secreting Cells | 1 | 2021 | 899 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2014 | 422 | 0.110 |
Why?
|
Anthropometry | 1 | 2017 | 1346 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 788 | 0.100 |
Why?
|
Neutrophils | 1 | 2024 | 3786 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2024 | 14486 | 0.090 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1461 | 0.090 |
Why?
|
Aged | 11 | 2024 | 171446 | 0.090 |
Why?
|
ROC Curve | 2 | 2016 | 3628 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6517 | 0.090 |
Why?
|
Animals | 11 | 2024 | 169222 | 0.090 |
Why?
|
Feces | 1 | 2017 | 1510 | 0.090 |
Why?
|
Blotting, Western | 2 | 2016 | 5024 | 0.090 |
Why?
|
Colectomy | 1 | 2015 | 696 | 0.090 |
Why?
|
Apolipoproteins C | 1 | 2010 | 59 | 0.090 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 20 | 0.090 |
Why?
|
Phosphatidylcholines | 2 | 2014 | 406 | 0.080 |
Why?
|
Prospective Studies | 3 | 2021 | 54924 | 0.080 |
Why?
|
Homeostasis | 1 | 2021 | 3348 | 0.080 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 506 | 0.080 |
Why?
|
Th17 Cells | 1 | 2016 | 791 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2019 | 3073 | 0.080 |
Why?
|
Adenoma | 1 | 2019 | 2159 | 0.080 |
Why?
|
Fasting | 1 | 2015 | 1609 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4045 | 0.080 |
Why?
|
Mice | 6 | 2024 | 82024 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12075 | 0.070 |
Why?
|
Models, Chemical | 2 | 2007 | 610 | 0.070 |
Why?
|
Cell-Free System | 1 | 2008 | 339 | 0.070 |
Why?
|
Myocardium | 1 | 2021 | 4788 | 0.070 |
Why?
|
Hypobetalipoproteinemias | 1 | 2007 | 11 | 0.070 |
Why?
|
Dimyristoylphosphatidylcholine | 1 | 2007 | 26 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2016 | 5902 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12828 | 0.070 |
Why?
|
Chylomicrons | 1 | 2006 | 27 | 0.070 |
Why?
|
Atherosclerosis | 2 | 2017 | 3433 | 0.070 |
Why?
|
Apolipoprotein B-100 | 1 | 2007 | 157 | 0.070 |
Why?
|
Gelsolin | 1 | 2007 | 189 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2333 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 13042 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2429 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6606 | 0.070 |
Why?
|
Carrier Proteins | 3 | 2010 | 4937 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6429 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13000 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5884 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2018 | 2401 | 0.060 |
Why?
|
Protein Biosynthesis | 2 | 2014 | 2094 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 7065 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3932 | 0.060 |
Why?
|
Spodoptera | 1 | 2005 | 140 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7140 | 0.060 |
Why?
|
Glycosylation | 1 | 2017 | 1100 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15867 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 40214 | 0.060 |
Why?
|
Peptide Fragments | 2 | 2009 | 5151 | 0.060 |
Why?
|
Fimbriae, Bacterial | 1 | 2004 | 138 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18344 | 0.060 |
Why?
|
Young Adult | 5 | 2018 | 60048 | 0.060 |
Why?
|
Phosphorylation | 2 | 2024 | 8314 | 0.060 |
Why?
|
Hydrolysis | 1 | 2005 | 646 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3858 | 0.050 |
Why?
|
Biophysics | 1 | 2005 | 379 | 0.050 |
Why?
|
Ketone Bodies | 1 | 2023 | 76 | 0.050 |
Why?
|
Bacterial Adhesion | 1 | 2004 | 305 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4362 | 0.050 |
Why?
|
Actins | 2 | 2009 | 2064 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1926 | 0.050 |
Why?
|
Kinetics | 2 | 2010 | 6328 | 0.050 |
Why?
|
Amino Acids | 1 | 2009 | 1716 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4261 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1683 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2442 | 0.050 |
Why?
|
Granulocytes | 1 | 2024 | 551 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10094 | 0.050 |
Why?
|
Motion | 1 | 2006 | 790 | 0.050 |
Why?
|
Risk Factors | 5 | 2024 | 74936 | 0.050 |
Why?
|
Cross-Linking Reagents | 1 | 2005 | 693 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7851 | 0.050 |
Why?
|
Protein Binding | 3 | 2010 | 9343 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3288 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15660 | 0.050 |
Why?
|
Acetylation | 1 | 2023 | 1055 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29979 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2024 | 588 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2006 | 1133 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1904 | 0.040 |
Why?
|
Tea | 1 | 2021 | 290 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6973 | 0.040 |
Why?
|
Transfection | 1 | 2017 | 5757 | 0.040 |
Why?
|
Registries | 1 | 2016 | 8377 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22287 | 0.040 |
Why?
|
Escherichia coli | 3 | 2009 | 4215 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11883 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13665 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16041 | 0.040 |
Why?
|
Up-Regulation | 1 | 2017 | 4146 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2014 | 13420 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 665 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2017 | 4289 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59598 | 0.040 |
Why?
|
Israel | 1 | 2019 | 726 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1011 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17617 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 13053 | 0.030 |
Why?
|
Caffeine | 1 | 2021 | 703 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4576 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1968 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18062 | 0.030 |
Why?
|
Beverages | 1 | 2021 | 819 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2201 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12536 | 0.030 |
Why?
|
Receptor, Adenosine A2A | 1 | 2016 | 129 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1966 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 788 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21532 | 0.030 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2016 | 205 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2017 | 221 | 0.030 |
Why?
|
Ileostomy | 1 | 2015 | 122 | 0.030 |
Why?
|
Triolein | 1 | 2014 | 9 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39345 | 0.030 |
Why?
|
Attitude | 1 | 2019 | 771 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5794 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23642 | 0.030 |
Why?
|
Platelet Activation | 1 | 2017 | 644 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3720 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2017 | 767 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 627 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 81746 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7241 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1616 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2871 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2085 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 422 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41749 | 0.030 |
Why?
|
Adenosine | 1 | 2017 | 820 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2744 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1524 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7445 | 0.020 |
Why?
|
Adolescent | 2 | 2017 | 89155 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12795 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 992 | 0.020 |
Why?
|
Length of Stay | 2 | 2016 | 6495 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3396 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1642 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 2011 | 174 | 0.020 |
Why?
|
Rats | 1 | 2017 | 23751 | 0.020 |
Why?
|
Surface Properties | 1 | 2014 | 1165 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10470 | 0.020 |
Why?
|
Hepacivirus | 1 | 2018 | 1342 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1495 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4176 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2011 | 526 | 0.020 |
Why?
|
Lipoproteins, IDL | 1 | 2010 | 18 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 938 | 0.020 |
Why?
|
Brefeldin A | 1 | 2010 | 68 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8740 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4938 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 924 | 0.020 |
Why?
|
Microsomes | 1 | 2010 | 252 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2515 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2543 | 0.020 |
Why?
|
Viscoelastic Substances | 1 | 2009 | 21 | 0.020 |
Why?
|
Buffers | 1 | 2009 | 143 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1443 | 0.020 |
Why?
|
Lymphocytes | 1 | 2017 | 2614 | 0.020 |
Why?
|
Threonine | 1 | 2010 | 273 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2660 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3703 | 0.020 |
Why?
|
Binding Sites | 2 | 2010 | 6022 | 0.020 |
Why?
|
Adsorption | 1 | 2009 | 198 | 0.020 |
Why?
|
Income | 1 | 2017 | 1878 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1835 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3813 | 0.020 |
Why?
|
Psychometrics | 1 | 2018 | 3062 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 272 | 0.020 |
Why?
|
Chickens | 1 | 2010 | 845 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5694 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4444 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6314 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2721 | 0.020 |
Why?
|
Water | 1 | 2014 | 1421 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6786 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2893 | 0.020 |
Why?
|
Alanine | 1 | 2010 | 614 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6611 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6339 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4258 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5209 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.010 |
Why?
|
Fimbriae Proteins | 1 | 2004 | 133 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8744 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5458 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7597 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10627 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9666 | 0.010 |
Why?
|
Primary Health Care | 1 | 2019 | 4746 | 0.010 |
Why?
|
Coronary Disease | 1 | 2017 | 5919 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11068 | 0.010 |
Why?
|
Family Health | 1 | 2007 | 1255 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 6004 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2559 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9412 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10396 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5955 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13489 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6515 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16723 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2004 | 1058 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20218 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15597 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10840 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36534 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42665 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15831 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11930 | 0.010 |
Why?
|
Child | 1 | 2016 | 80906 | 0.000 |
Why?
|
Mutation | 1 | 2004 | 30211 | 0.000 |
Why?
|